Mr. Hamed Shahbazi reports

WELL HEALTH LAUNCHES WELL RESEARCH, AN END-TO-END CLINICAL TRIAL PLATFORM BUILT ON CANADA'S LARGEST OUTPATIENT NETWORK

Well Health Technologies Corp. has launched Well Research, Well's consolidated clinical research brand. Well Research provides (i) full-service contract research organization (CRO) trial management, running early phase trials, (ii) site management organization (SMO) services, handling day-to-day participant recruitment and co-ordination within late-stage trial sites, and (iii) bioanalytical services across the complete range of trial phases, therapeutic areas and therapy modalities.

• Well Research is the clinical research brand of Well Health Technologies. Well Research offers the unique combination of full-service contract research organization (CRO) services in early phase trials, site management organization (SMO) execution at late-stage trial sites and bioanalytical services across every phase of clinical trials. Together, these capabilities span the full clinical trial value chain and allow sponsors and providers to enrol the right trial participants quickly and reliably.
• Well Research is supported by four of Well's differentiated assets: Canada's largest outpatient clinic network (275 clinics supporting five million-plus annual patient visits), WellStar's provider network (45,000+ providers), the WellTrust patient consent platform (100,000-plus patient consents), and HealWell AI's Darwen platform for feasibility assessment and protocol-participant matching.

Clinical research exists to improve health outcomes; however, sponsors continue to struggle to enrol the right trial participants quickly and reliably. Well Research addresses this challenge by delivering the full clinical trial value chain through its CRO, SMO and bioanalytical capabilities, supported by four of Well's differentiated assets:

1. Canada's largest outpatient clinic network -- Well's 275 clinics across Canada, supporting more than five million patient visits per year.
2. WellStar's provider network -- Well's technology subsidiary connects a network of more than 45,000 health care practitioners.
3. WellTrust patient consent platform -- Well's consent-first platform, through which more than 100,000 patients have already consented to be contacted about clinical trial opportunities, with the company continuing to grow its consented patient base.
4. HealWell AI's Darwen platform -- Delivers AI-enabled feasibility assessment and protocol-participant matching to support clinical trial recruitment.

Hamed Shahbazi, founder, chairman and chief executive officer of Well, commented: "Well Research reflects a simple idea: for the right patients, in the right setting, a clinical trial is a specialized form of care. We've spent years building the largest outpatient clinic network in Canada, a provider network that touches tens of thousands of health care providers, and a consent platform that lets patients participate in research on their own terms. Well Research brings those pieces together into a single, dependable offering for sponsors and providers, and we believe it can become a meaningful growth driver for our network over time."

Well Research comprises BioPharma Services Inc. (BPSI), a full-service CRO and bioanalytical laboratory with 20 years of operating history, and Canadian Phase Onward (CPO), its SMO, both held through the company's clinical research joint venture with HealWell AI.

About Well Health Technologies Corp.

Well Health Technologies is Canada's largest outpatient health care company and a leading provider of technology-enabled healthcare solutions. Well is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI and every piece of health data is protected. Well owns and operates 275 clinics in Canada, supporting more than five million annual patient visits. Through its subsidiary WellStar, Well provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services. Well provides cybersecurity services through its CyberWell subsidiary. Well is publicly traded on the Toronto Stock Exchange under the symbol WELL and on the OTC Exchange under the symbol WHTCF.

We seek Safe Harbor.